BIT Pharma GmbH: Clinical Trials

1 trial sponsored by BIT Pharma GmbH, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Completed 1

Follow BIT Pharma GmbH: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Safety and Efficacy Study of NicaPlant® in Aneurysmal Subarachnoid Haemorrhage Patients Undergoing Aneurysm Clipping
Nicardipine, Standard of care - Aneurysmal Subarachnoid Hemorrhage
Phase 2CompletedBIT Pharma GmbH412020-04-052023-07-12

Conditions studied

Subarachnoid Hemorrhage (1)

Interventions

Nicardipine (1)  ·  Standard of Care (1)

Countries

Austria (1)  ·  Germany (1)

Results publications

PMID 39158893

NIH funding

2017 (1)